GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Asset Turnover

Krebs Biochemicals & Industries (BOM:524518) Asset Turnover : 0.07 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Krebs Biochemicals & Industries's Revenue for the three months ended in Mar. 2024 was ₹119.7 Mil. Krebs Biochemicals & Industries's Total Assets for the quarter that ended in Mar. 2024 was ₹1,781.7 Mil. Therefore, Krebs Biochemicals & Industries's Asset Turnover for the quarter that ended in Mar. 2024 was 0.07.

Asset Turnover is linked to ROE % through Du Pont Formula. Krebs Biochemicals & Industries's annualized ROE % for the quarter that ended in Mar. 2024 was 19.62%. It is also linked to ROA % through Du Pont Formula. Krebs Biochemicals & Industries's annualized ROA % for the quarter that ended in Mar. 2024 was -13.13%.


Krebs Biochemicals & Industries Asset Turnover Historical Data

The historical data trend for Krebs Biochemicals & Industries's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Asset Turnover Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.26 0.34 0.29 0.29

Krebs Biochemicals & Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.06 0.08 0.07 0.07

Competitive Comparison of Krebs Biochemicals & Industries's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krebs Biochemicals & Industries's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Asset Turnover falls into.



Krebs Biochemicals & Industries Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Krebs Biochemicals & Industries's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=504.215/( (1749.817+1781.747)/ 2 )
=504.215/1765.782
=0.29

Krebs Biochemicals & Industries's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=119.729/( (0+1781.747)/ 1 )
=119.729/1781.747
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Krebs Biochemicals & Industries  (BOM:524518) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Krebs Biochemicals & Industries's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-233.876/-1192.167
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-233.876 / 478.916)*(478.916 / 1781.747)*(1781.747/ -1192.167)
=Net Margin %*Asset Turnover*Equity Multiplier
=-48.83 %*0.2688*-1.4945
=ROA %*Equity Multiplier
=-13.13 %*-1.4945
=19.62 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Krebs Biochemicals & Industries's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-233.876/1781.747
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-233.876 / 478.916)*(478.916 / 1781.747)
=Net Margin %*Asset Turnover
=-48.83 %*0.2688
=-13.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Krebs Biochemicals & Industries Asset Turnover Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries (BOM:524518) Business Description

Traded in Other Exchanges
Address
Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines